Beijing Strong Biotechnologies, Inc. (300406.SZ): The folic acid testing kit has obtained the medical device registration certificate.
Jiufeng Biological (300406.SZ) announced that the company recently received the "Medical Device Registration Certificate" issued by the Beijing Municipal Medical Products Administration. The product is a folic acid assay kit (magnetic microparticle chemiluminescent immunoassay). This kit is used for the in vitro quantitative determination of folic acid (FA) content in human serum or plasma. The acquisition of the medical device registration certificate for the above product enriches the company's product line in the subfield of in vitro diagnostic chemiluminescence, which is beneficial for further enhancing the company's core competitiveness and market expansion capabilities.
Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that it has recently received the "Medical Device Registration Certificate" issued by the Beijing Municipal Medical Products Administration. The product is a folic acid determination kit (magnetic microparticle chemiluminescence immunoassay). This kit is used for the in vitro quantitative determination of the content of folic acid (FA) in human serum or plasma. The acquisition of the medical device registration certificate for the above product enriches the company's product line in the niche field of in vitro diagnostic chemiluminescence, which is beneficial for further enhancing the company's core competitiveness and market expansion capabilities.
Related Articles

WING ON CO (00289) repurchased 13,000 shares at a cost of HKD 169,000 on September 2.

Hunan Warrant Pharmaceutical (688799.SH) subsidiary chemical raw material drug Elamomed has been approved for listing.
.png)
SSY GROUP (02005): The trustee has purchased a total of 1.2 million shares under the restricted share award plan.
WING ON CO (00289) repurchased 13,000 shares at a cost of HKD 169,000 on September 2.

Hunan Warrant Pharmaceutical (688799.SH) subsidiary chemical raw material drug Elamomed has been approved for listing.

SSY GROUP (02005): The trustee has purchased a total of 1.2 million shares under the restricted share award plan.
.png)
RECOMMEND





